Accretion Nutraveda Limited
IPO Details
Subscription
Lot Distribution
Reservation
Company Fin.
₹27(20.93%)
Premium (ELP)
Accretion Nutraveda Limited's successfully completed its Initial Public Offering and commenced trading on Feb 04, 2026 at the BSE exchange. The company raised 19,20,000 Shares through this public offering, comprising 19,20,000 Shares in fresh capital.
The IPO was priced within the band of ₹122 to ₹129, with minimum application lots of 1000 shares. The offering attracted significant investor interest during its subscription period from Jan 28, 2026 to Jan 30, 2026.
Share allotment was finalized on Feb 02, 2026, distributing equity to successful applicants. The stock's subsequent listing marked a significant milestone in the company's corporate history, providing public market liquidity to shareholders.
Investors can bid starting from the minimum lot size specified for this IPO, and only in multiples of that lot size. The table below shows the minimum and maximum investment for retail investors and HNIs in terms of lots, quantity, and amount.
Incorporated in 2021, Accretion Nutraveda is engaged in the manufacturing of Ayurvedic and nutraceutical products across multiple dosage forms such as tablets, capsules, oral liquids, powders, oils, and external applications including balms, creams, and gels, operating as a Contract Development and Manufacturing Organization (CDMO) for both domestic and international markets including Sri Lanka, Singapore, and the USA. The company blends classical Ayurvedic formulations with modern nutraceutical science to address wellness segments such as liver care, women’s health, bone and joint health, cognitive support, and respiratory health, with its revenue primarily driven by domestic sales and merchant exports on a loan license basis, along with a growing contribution from direct exports. It operates a 10,763 sq. ft. manufacturing facility in Gujarat equipped with modern infrastructure, multiple air handling units, segregated processing areas, and quality control systems, and holds certifications including GMP, WHO-GMP, FSSC 22000, ISO 9001:2015, ISO 45001:2018, Halal, and FSSAI.
Note : "Calculations for ‘Shares Offered’ and ‘Total Amount’ are based on the highest price in the issue price band."
- Experienced Management Team: Promoters and leaders with strong expertise in Ayurvedic and nutraceutical manufacturing.
- Diverse Product Portfolio: Offers products across various therapeutic and wellness segments.
- Quality & Compliance Focus: Backed by multiple global certifications ensuring high standards.
- Manufacturing Operational Risk: Equipment failures, accidents, or natural events may disrupt production.
- Regulatory & Compliance Risk: Past filing discrepancies may lead to regulatory issues.
- Customer Concentration Risk: Dependence on a few customers exposes revenue to potential volatility.
- Mr. Mayur Popatlal Sojitra
- Mr. Ankurkumar Shantilal Patel
- Mr. Paraskumar Vinubhai Parmar
- Mr. Hardik Mukundbhai Prajapati
- Mr. Harshad Nanubhai Rathod
- Mr. Vivek Ashok Kumar Patel
Accretion Nutraveda Limited
Kfin Technologies Limited